SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-18-003818
Filing Date
2018-01-24
Accepted
2018-01-25 08:56:01
Documents
4
Period of Report
2018-02-21
Effectiveness Date
2018-01-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A a18-2558_1def14a.htm DEF 14A 492071
2 GRAPHIC g25581bgi001.jpg GRAPHIC 5666
3 GRAPHIC g25581bci001.jpg GRAPHIC 5666
4 GRAPHIC g25581bci002.jpg GRAPHIC 2850
  Complete submission text file 0001104659-18-003818.txt   513099
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36856 | Film No.: 18546715
SIC: 2834 Pharmaceutical Preparations